Join us for the inaugural Forbes-Taubman Symposium for Cancer Discovery, co-sponsored by the A. Alfred Taubman Medical Research Institute and the Forbes Institute for Cancer Discovery. Four eminent speakers will discuss their latest advances in the understanding of cancer metabolism and how this research is leading to new avenues for cancer therapy.

Speakers include Michael Lisanti, MD, PhD, Chair in Translational Medicine at the University of Salford (UK); Michael Pollak, MD, Alexander-Goldfarb Research Chair in Medical Oncology, McGill University; Max Wicha, MD, Director of the Forbes Institute for Cancer Discovery, University of Michigan, and Costas Lyssiotis, PhD, Assistant Professor of Molecular and Integrative Physiology, University of Michigan. Opening remarks will be offered by Eric Fearon, MD, PhD, Director of the University of Michigan Comprehensive Cancer Center.

All welcome, no registration required. Coffee and networking at 8:00 a.m. in the lobby of the AAT-BSRB